Eli Lilly Among Top 10 Dividend Stocks to Buy According to D. E. Shaw
D. E. Shaw has included Eli Lilly and Company (LLY) among its top 10 dividend stocks to buy. Jefferies also raised its price target to $1,350 from $1,330, maintaining a Buy rating following full data release.
Key Numbers
Investment firm D. E. Shaw has included Eli Lilly and Company (NYSE:LLY) in its list of the 10 best dividend stocks to buy. The inclusion comes as Jefferies raised its price target on the stock to $1,350 from $1,330, reiterating a Buy rating.
Recommendation Change
- New Price Target: $1,350
- Old Price Target: $1,330
- Rating: Buy
Analyst Rationale
The price target increase followed the release of full data from clinical trials or financial results (source did not specify). Analysts believe the company has strong fundamentals supporting dividend growth.
Context
Eli Lilly is a leading pharmaceutical company with a history of increasing dividends. Its inclusion by D. E. Shaw boosts investor confidence. No conflicting recommendations from other analysts were mentioned.
What to Make of It
The raised price target and D. E. Shaw's endorsement reflect a positive outlook for Eli Lilly. However, investors should assess risks and returns based on their own investment goals.
Frequently Asked Questions
Found this useful? Share it